|
|
Volumn 6, Issue 10, 1997, Pages 1395-1411
|
|
Muscarinic agonists for the treatment of Alzheimer's disease: Progress and perspectives
|
|
Author keywords
AF series (AF102B cevimeline ; AF150(S); Alzheimer's disease; Amyloid precursor protein; Animal models; apoE knock out mice; CI 979(milameline); Clinical studies; Functional selectivity; G proteins; Lu 25 109; LY 246708 (xanomeline); M1 selective; Muscarinic acetylcholine receptor; Muscarinic agonists; Neurotrophic effects; PD 151832; SB 202026 (sabcomeline); Tau protein; WAL 2014 (talsaclidine); YM 796
|
|
Indexed keywords
2,8 DIMETHYL 3 METHYLENE 1 OXA 8 AZASPIRO[4,5]DECANE TARTARATE MONOHYDRATE;
2,8 DIMETHYL 3 METHYLENE 1 OXA 8 AZASPIRO[4.5]DECANE;
ALVAMELINE;
AMYLOID PRECURSOR PROTEIN;
CEVIMELINE;
LY 287041;
MILAMELINE;
MUSCARINIC AGENT;
MUSCARINIC RECEPTOR;
RECEPTOR SUBTYPE;
SABCOMELINE;
TALSACLIDINE;
UNCLASSIFIED DRUG;
XANOMELINE;
ALZHEIMER DISEASE;
COGNITION;
HUMAN;
REVIEW;
SIGNAL TRANSDUCTION;
|
|
EID: 0030764026
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.6.10.1395 Document Type: Review |
|
Times cited : (32)
|
|
References (101)
|
